» Articles » PMID: 34150172

Combined Detection of ACL and β2-GP1 in Diagnosis of Adverse Pregnancy

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2021 Jun 21
PMID 34150172
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To illustrate the significance of combined detection of anti cardiolipin (ACL) and anti-β2-glycoprotein 1 (β2-GP1) in the diagnosis of adverse pregnancy.

Methods: 60 postnatal women with adverse pregnancy presented to our hospital from March 2019 to March 2020 were enrolled as the experimental group, and 60 postnatal women with normal delivery in the same period were selected as the control group. The levels of ACL, β2-GP1 were measured to analyze the significance of the integrated detection in the diagnosis of adverse pregnancy.

Results: No obvious differences were observed in mean age, mean gestational week, mean height, number of cases of primigravida and multiparous women, educational background, place of residence between two groups ( > 0.05). The number of cases of positive β2-GP1-IgG and β2-GP1-IgM tests in experimental group were remarkably higher ( < 0.05). The number of β2-GP1-IgA positive cases in the two kinds of parturients was not notably different ( > 0.05). The ACL of the experimental parturients had a notably higher number of β2-GP1-positive cases ( < 0.001), and the combined positive cases of the experimental parturients had notably higher serum BPA and resistin levels ( < 0.001). The incidence of fetal growth restriction, premature delivery and placental abruption of experimental group were higher than those of control group (P < 0.05). There was no stillbirth in both groups.

Conclusions: The positive expression of ACL with β2-GP1 is the culprit of adverse pregnancy, and the combined diagnosis can greatly improve the clinical screening rate of adverse pregnancy and provide more evidence for subsequent treatment.

Citing Articles

Potent prophylactic cancer vaccines harnessing surface antigens shared by tumour cells and induced pluripotent stem cells.

Li N, Qin H, Zhu F, Ding H, Chen Y, Lin Y Nat Biomed Eng. 2024; 9(2):215-233.

PMID: 39730914 DOI: 10.1038/s41551-024-01309-0.

References
1.
Li M, Li S, He Q, Liang Z, Wang L, Wang Q . Hepatitis E-related adverse pregnancy outcomes and their prevention by hepatitis E vaccine in a rabbit model. Emerg Microbes Infect. 2019; 8(1):1066-1075. PMC: 6711181. DOI: 10.1080/22221751.2019.1643260. View

2.
Farland L, Prescott J, Sasamoto N, Tobias D, Gaskins A, Stuart J . Endometriosis and Risk of Adverse Pregnancy Outcomes. Obstet Gynecol. 2019; 134(3):527-536. PMC: 6922084. DOI: 10.1097/AOG.0000000000003410. View

3.
Davis S, Dylewski J, Shah P, Holmen J, You Z, Chonchol M . Risk of adverse maternal and fetal outcomes during pregnancy in living kidney donors: A matched cohort study. Clin Transplant. 2018; 33(1):e13453. PMC: 6342653. DOI: 10.1111/ctr.13453. View

4.
Robinson J, Inderhaug E, Harlem T, Spalding T, Brown Jr C . Anterior Cruciate Ligament Femoral Tunnel Placement: An Analysis of the Intended Versus Achieved Position for 221 International High-Volume ACL Surgeons. Am J Sports Med. 2020; 48(5):1088-1099. DOI: 10.1177/0363546520906158. View

5.
Quattrocchi T, Baviera G, Pochiero T, Basile F, Rizzo L, Santamaria A . Maternal serum PAPP-A as an early marker of obstetric complications?. Fetal Diagn Ther. 2014; 37(1):33-6. DOI: 10.1159/000365147. View